Results of the German IPEP study evaluating the tolerability, efficacy, and acceptance of fulvestrant (Faslodex(r)) under routine clinical conditions in advanced breast cancer

Authors :: Anke Thomas
C. Moers
M. Warm
K. Ziegler
Ronald E. Kates
Nadia Harbeck
Source :: European Journal of Cancer Supplements. 6:127
Publication Year :: 2008
Publisher :: Elsevier BV, 2008.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Fulvestrant
business.industry
Advanced breast
Cancer
medicine.disease
language.human_language
German
Tolerability
Internal medicine
language
Medicine
business
medicine.drug

Full Text Access

Tools